Prognostic value of hyperuricemia in chronic heart failure;Valor pronóstico de la hiperuricemia en la insuficiencia cardíaca crónica

Revista Medica de Chile

Volumn 132, Issue 9, 2004, Pages 1031-1036

  Martínez S, Alejandro ^a   González M, Alejandro ^a   Cerda D, Cristián ^a   Pérez C, Pedro ^a   Castro G, Pablo ^a   Pérez P, Osvaldo ^a   Isa P, Rodrigo ^a   Corbalán H, Ramón ^a  

^a Rheumatology Service   (Chile)

Author keywords

Heart failure, congestive; Hyperuricemia; Stroke volume; Ventricular ejection fraction

Indexed keywords

CATECHOLAMINE; CREATININE; URIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART GRAFT; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERURICEMIA; MALE; MEASUREMENT; MORTALITY; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PROGNOSIS; URIC ACID BLOOD LEVEL;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHRONIC DISEASE; CREATININE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE VOLUME;

EID: 12444326202     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. MACINTYRE K, CAPEWELL S, STEWART S, CHALMERS J, BOYD J, FINLAYSON A ET AL. Evidence of improving prognosis in heart failure: trends in case fatality in 66.547 patients hospitalized between 1986 and 1995. Circulation 2000; 102: 1126-31.
2. COHN JN, JOHNSON GR, SHABETAI R, LOEB H, TRISTANI F, RECTOR T ET AL. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhymias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87: VI5-16.
3. ANKER S, DOEHNER W, RAUCHAUS M, SHARMA R, FRANCIS D, KNOSALLA C ET AL. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. Circulation 2003; 107: 1991-7.
4. MARTÍNEZ A, PÉREZ P, OSSA C, CORBALÁN R, JALIL J, CASTRO P ET AL. La hiperuricemia es un marcador del umbral anaeróbico en la insuficiencia cardíaca crónica. Rev Méd Chile 2001; 129: 499-504.
5. DE JONG JW, SCHOEMAKER RG, DE JONGE R, BERNOCCHI P, KEIJZER E, HARRISON R ET AL. Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol 2000; 32: 2083-9.
6. SAWYER D, SIWIK D, XIAO L, PIMENTEL D, SINGH K, COLUCCI W. Role of Oxidative Stress in Myocardial Hypertrophy and Failure. J Mol Cell Cardiol 2002; 34: 379-88.
7. LANDMESSER U, SPIEKERMANN S, DIKALOV S, TATGE H, WILKE R, KOHLER C ET AL. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure. Role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002; 106: 3073-8.
8. DUPONT GP, HUECKSTEADT TP, MARSHALL BC, RYAN US, MICHAEL JR, HOIDAL JR. Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest 1992; 89: 197-202.
9. HASSOUN PM, YU FS, SHEDD AL, ZULUETA JJ, THANNICKAL VJ, LANZILLO JJ ET AL. Regulation of endothelial xanthine dehydrogenase/xanthine oxidase gene expression by oxygen tension. Am J Physiol 1994; 266: L163-71.
10. MERVAALA EM, CHENG ZJ, TIKKANEN I, LAPATTO R, NURMINEN K, VAPAATALO H ET AL. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension 2001; 37: 414-8.
11. DHALLA NS, TEMSAH RM, NETTICADAN T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-73.
12. IDE T, TSUTSUI H, KINUGAWA S, SUEMATSU N, HAYASHIDANI S, ICHIKAWA K ET AL. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing human myocardium. Circ Res 2000; 86: 152-7.
13. CAPPOLA TP, KASS DA, NELSON GS, BERGER RD, ROSAS GO, KOBEISSI ZA ET AL. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 104: 2407-11.
14. DOEHNER W, SCHOENE N, RAUCHHAU S, LEYVA-LEON F, PAVITT D, REAVELEY D ET AL. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure. Results from 2 placebo-controlled studies. Circulation 2002; 105: 2619-24.
15. FARQUHARSON CA, BUTLER R, HILL A, BELCH JJ, STRUTHERS AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002; 106: 221-6.